CTRI/2021/05/033326
Not yet recruiting
Phase 2
A Randomised open controlled clinical trial to evaluate the efficacy of Indrayavadi yoga in Asrugdara with special reference to Dysfunctional uterine bleeding (DUB).
Priyanka Dilipkumar Sahu0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: N00-N99- Diseases of the genitourinary system
- Sponsor
- Priyanka Dilipkumar Sahu
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Diagnosed patients of DUB having age group 20 to 45 Years .
- •2\.Selection irrespective of marital status, parity, socio\-economic status.
- •3\.Patient having sign and symptoms of Asrugdara.
- •4\.Excessive bleeding more than two consecutive cycles.
- •5\.Those having Intermenstrual bleeding
- •6\.Excessive bleeding per vagina during menstruation either in amount or in duration or both.
- •7\.Hb \> 8%gm/dl.
Exclusion Criteria
- •1\.Patients having blood dyscrasias
- •2\.Major systemic disease likely to influence menstrual cycle like HTN , DM , TB , HIV , Thyroid, Kidney
- •3\.Known Patients of malignancy, cervical erosion, polyp, adenomyosis, pelvic endometriosis, tubo\-ovarian mass , PCOD.
- •4\.Known case of structural anomalies of genital organs.
- •5\.Patients using IUCD.
- •6\.Patients undergoing treatment for any other serious illness.
- •7\.Those having postmenopausal bleeding.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
study the effect of neem leaf juice in worm infestation in childreCTRI/2022/07/044339Yashwant ayurvedic College
Completed
Not Applicable
Efficacy of a maintenance therapy with supplements containing indole-3-carbinol (I3C) and epigallocatechin-3-gallate (EGCG) in ovarian cancer patientsOvarian cancerCancer - Ovarian and primary peritonealACTRN12616000394448Russian Scientific Center of Roentgenoradiology284
Not yet recruiting
Phase 2
To study the efficacy of garlic milk decoction in decreased breast milk secretion.CTRI/2022/04/042216ALKA SARVAJEET SINGH
Active, not recruiting
Phase 1
A study of the safety and efficacy of Eryxin in patients with rheumatoid arthritisSafety and efficacy in patients with rheumatoid arthritisMusculoskeletal DiseasesISRCTN13331870amangan Pharm Plant LTD60
Not yet recruiting
Phase 2
Shunthyadi Payasa in gridhrasiHealth Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhereCTRI/2024/01/061894Dr Aishwarya Uday Bhosale